Report Detail
Global Deferasirox Market Growth 2019-2024
- RnM3050817 |
- 05 March, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.
The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.
According to this study, over the next five years the Deferasirox market will register a 4.7% CAGR in terms of revenue, the global market size will reach US$ 2990 million by 2024, from US$ 2270 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Deferasirox business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Deferasirox market by product type, application, key manufacturers and key regions and countries.
This study considers the Deferasirox value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
500 mg/Tablet
250 mg/Tablet
125 mg/Tablet
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Transfusional Iron Overload
NTDT Caused Iron Overload
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Cipla
Sun Pharma
Natco Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Deferasirox consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Deferasirox market by identifying its various subsegments.
Focuses on the key global Deferasirox manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Deferasirox with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Deferasirox submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Deferasirox Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Deferasirox Consumption 2014-2024
- 2.1.2 Deferasirox Consumption CAGR by Region
- 2.2 Deferasirox Segment by Type
- 2.2.1 500 mg/Tablet
- 2.2.2 250 mg/Tablet
- 2.2.3 125 mg/Tablet
- 2.2.4 Others
- 2.3 Deferasirox Consumption by Type
- 2.3.1 Global Deferasirox Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Deferasirox Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Deferasirox Sale Price by Type (2014-2019)
- 2.4 Deferasirox Segment by Application
- 2.4.1 Transfusional Iron Overload
- 2.4.2 NTDT Caused Iron Overload
- 2.5 Deferasirox Consumption by Application
- 2.5.1 Global Deferasirox Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Deferasirox Value and Market Share by Application (2014-2019)
- 2.5.3 Global Deferasirox Sale Price by Application (2014-2019)
3 Global Deferasirox by Players
- 3.1 Global Deferasirox Sales Market Share by Players
- 3.1.1 Global Deferasirox Sales by Players (2017-2019)
- 3.1.2 Global Deferasirox Sales Market Share by Players (2017-2019)
- 3.2 Global Deferasirox Revenue Market Share by Players
- 3.2.1 Global Deferasirox Revenue by Players (2017-2019)
- 3.2.2 Global Deferasirox Revenue Market Share by Players (2017-2019)
- 3.3 Global Deferasirox Sale Price by Players
- 3.4 Global Deferasirox Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Deferasirox Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Deferasirox Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Deferasirox by Regions
- 4.1 Deferasirox by Regions
- 4.1.1 Global Deferasirox Consumption by Regions
- 4.1.2 Global Deferasirox Value by Regions
- 4.2 Americas Deferasirox Consumption Growth
- 4.3 APAC Deferasirox Consumption Growth
- 4.4 Europe Deferasirox Consumption Growth
- 4.5 Middle East & Africa Deferasirox Consumption Growth
5 Americas
- 5.1 Americas Deferasirox Consumption by Countries
- 5.1.1 Americas Deferasirox Consumption by Countries (2014-2019)
- 5.1.2 Americas Deferasirox Value by Countries (2014-2019)
- 5.2 Americas Deferasirox Consumption by Type
- 5.3 Americas Deferasirox Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Deferasirox Consumption by Countries
- 6.1.1 APAC Deferasirox Consumption by Countries (2014-2019)
- 6.1.2 APAC Deferasirox Value by Countries (2014-2019)
- 6.2 APAC Deferasirox Consumption by Type
- 6.3 APAC Deferasirox Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Deferasirox by Countries
- 7.1.1 Europe Deferasirox Consumption by Countries (2014-2019)
- 7.1.2 Europe Deferasirox Value by Countries (2014-2019)
- 7.2 Europe Deferasirox Consumption by Type
- 7.3 Europe Deferasirox Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Deferasirox by Countries
- 8.1.1 Middle East & Africa Deferasirox Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Deferasirox Value by Countries (2014-2019)
- 8.2 Middle East & Africa Deferasirox Consumption by Type
- 8.3 Middle East & Africa Deferasirox Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Deferasirox Distributors
- 10.3 Deferasirox Customer
11 Global Deferasirox Market Forecast
- 11.1 Global Deferasirox Consumption Forecast (2019-2024)
- 11.2 Global Deferasirox Forecast by Regions
- 11.2.1 Global Deferasirox Forecast by Regions (2019-2024)
- 11.2.2 Global Deferasirox Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Deferasirox Forecast by Type
- 11.8 Global Deferasirox Forecast by Application
12 Key Players Analysis
- 12.1 Novartis
- 12.1.1 Company Details
- 12.1.2 Deferasirox Product Offered
- 12.1.3 Novartis Deferasirox Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novartis News
- 12.2 Cipla
- 12.2.1 Company Details
- 12.2.2 Deferasirox Product Offered
- 12.2.3 Cipla Deferasirox Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Cipla News
- 12.3 Sun Pharma
- 12.3.1 Company Details
- 12.3.2 Deferasirox Product Offered
- 12.3.3 Sun Pharma Deferasirox Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Sun Pharma News
- 12.4 Natco Pharma
- 12.4.1 Company Details
- 12.4.2 Deferasirox Product Offered
- 12.4.3 Natco Pharma Deferasirox Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Natco Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Deferasirox . Industry analysis & Market Report on Deferasirox is a syndicated market report, published as Global Deferasirox Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Deferasirox market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
